{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:27:52Z","timestamp":1790645272602,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/13\/3\/29924"],"award-info":[{"award-number":["PG\/13\/3\/29924"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.yjmcc.2018.05.015","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T05:00:33Z","timestamp":1527310833000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca2+ handling dysfunction in rats with pulmonary artery hypertension"],"prefix":"10.1016","volume":"120","author":[{"given":"Ewan D.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Drinkhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Pervolaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Stones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek S.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Calaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2018.05.015_bb0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00215514","article-title":"Outcomes of beta-blocker use in pulmonary arterial hypertension: a propensity-matched analysis","volume":"46","author":"Bandyopadhyay","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0010","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1529\/biophysj.106.103069","article-title":"A new approach to the detection and statistical classification of Ca2+ sparks","volume":"92","author":"Banyasz","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0015","doi-asserted-by":"crossref","first-page":"H2381","DOI":"10.1152\/ajpheart.01084.2011","article-title":"Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension","volume":"302","author":"Benoist","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0020","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/rccm.201003-0335OC","article-title":"Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats","volume":"182","author":"Bogaard","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.RES.76.5.790","article-title":"Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements","volume":"76","author":"Bouchard","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0030","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.111.245092","article-title":"Treatment of chronic heart failure with beta-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology","volume":"109","author":"Bristow","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/682223","article-title":"The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series)","volume":"5","author":"Bristow","year":"2015","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0040","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCRESAHA.116.303448","article-title":"Dependence of cardiac transverse tubules on the BAR domain protein amphiphysin II (BIN-1)","volume":"115","author":"Caldwell","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.yjmcc.2015.04.022","article-title":"T-tubule disease: relationship between t-tubule organization and regional contractile performance in human dilated cardiomyopathy","volume":"84","author":"Crossman","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0050","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.114.013895","article-title":"Inhibition of hypertrophy, per se, may not be a good therapeutic strategy in ventricular pressure overload: other approaches could be more beneficial","volume":"131","author":"Crozatier","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00051215","article-title":"beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure","volume":"46","author":"de Man","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCHEARTFAILURE.111.964494","article-title":"Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension","volume":"5","author":"de Man","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1085\/jgp.201311125","article-title":"Impact of detubulation on force and kinetics of cardiac muscle contraction","volume":"143","author":"Ferrantini","year":"2014","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0070","doi-asserted-by":"crossref","first-page":"G3","DOI":"10.1093\/eurheartj\/suw042","article-title":"Heart failure: an historical perspective","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.06.016","article-title":"Decreased creatine kinase is linked to diastolic dysfunction in rats with right heart failure induced by pulmonary artery hypertension","volume":"86","author":"Fowler","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/1440-1681.12898","article-title":"Diastolic dysfunction in pulmonary artery hypertension: creatine kinase and the potential therapeutic benefit of beta-blockers","volume":"45","author":"Fowler","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0090","first-page":"L363","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0095","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1164\/rccm.201311-2025LE","article-title":"Treatment of group I pulmonary arterial hypertension with carvedilol is safe","volume":"189","author":"Grinnan","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle","volume":"56","author":"Grossman","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09059180.00007109","article-title":"Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart","volume":"19","author":"Handoko","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00205","article-title":"Dynamic Action Potential Restitution Contributes to Mechanical Restitution in Right Ventricular Myocytes From Pulmonary Hypertensive Rats","volume":"9","author":"Hardy","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0115","doi-asserted-by":"crossref","first-page":"20477","DOI":"10.1074\/jbc.M115.650531","article-title":"Distribution and Function of Cardiac Ryanodine Receptor Clusters in Live Ventricular Myocytes","volume":"290","author":"Hiess","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1529\/biophysj.105.077214","article-title":"Interplay of ryanodine receptor distribution and calcium dynamics","volume":"91","author":"Izu","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2012.10.009","article-title":"Termination of calcium-induced calcium release by induction decay: an emergent property of stochastic channel gating and molecular scale architecture","volume":"54","author":"Laver","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0130","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/674770","article-title":"A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?","volume":"3","author":"Maarman","year":"2013","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cardiores.2004.04.013","article-title":"Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy","volume":"63","author":"McCrossan","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0145","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/CIRCRESAHA.111.262345","article-title":"Local beta-adrenergic stimulation overcomes source-sink mismatch to generate focal arrhythmia","volume":"110","author":"Myles","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","article-title":"Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach","volume":"35","author":"Nogueira-Ferreira","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/thx.2008.111955","article-title":"Pulmonary hypertension: a contraindication to the use of {beta}-adrenoceptor blocking agents","volume":"65","author":"Peacock","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003703","article-title":"Use of beta-Blockers in Pulmonary Hypertension","volume":"10","author":"Perros","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0165","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jacc.2014.11.050","article-title":"Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension","volume":"65","author":"Perros","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0175","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijcard.2012.03.071","article-title":"QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension","volume":"167","author":"Rich","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0180","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/01.RES.0000222028.92993.10","article-title":"Differential calcineurin\/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart","volume":"98","author":"Rossow","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-662-45805-1_5","article-title":"Rodent models of group 1 pulmonary hypertension","volume":"218","author":"Ryan","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0190","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","article-title":"Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload","volume":"131","author":"Schiattarella","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0195","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2012.01.368","article-title":"Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension","volume":"109","author":"So","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0200","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/CIRCHEARTFAILURE.114.001429","article-title":"beta-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis","volume":"7","author":"Thenappan","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCEP.111.967265","article-title":"Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension","volume":"5","author":"Umar","year":"2012","journal-title":"Circ. Arrhythm Electrophysiol."},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0210","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/13993003.00090-2016","article-title":"Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study","volume":"48","author":"van Campen","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0215","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.05.015_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/joim.12141","article-title":"The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF","volume":"275","author":"Wikstrand","year":"2014","journal-title":"J. Intern. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818301767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818301767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T15:01:58Z","timestamp":1569337318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818301767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"alternative-id":["S0022282818301767"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.05.015","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca2+ handling dysfunction in rats with pulmonary artery hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}